Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Faron Pharmaceuticals Share News (FARN)
FARN Share
Price
FARN Share
News
FARN Share
Chat
FARN Share
Trades8
FARN
Live RNS
FARN Share
Charts
FARN Level 2
Console
FARN Live
Share Price
FARN Broker
Ratings
FARN Directors
Deals
FARN Financial
Diary
FARN
Fundamentals
FARN Short
Positions
FARN
Media
FARN Company
Research
FARN Company
Timeline
Share Price Information for Faron Pharmaceuticals (FARN)
Last checked at -
Last checked at 
Intraday Faron Pharmaceuticals Share Chart
Faron Pharmaceuticals Notes Study Supporting Clevegen Programme
LONDON (Alliance News) - Faron Pharmaceuticals Oy on Monday said an article published in the Journal of Immunology has outlined the functional role of the company's Clever-1 treatment, part of its Clevegen cancer immunotherapy antibody programme.
Faron, which floated in London earlier this month, said the data published in the study supported Clever-1 as an immuosuppresive molecule and supports the use of Clevegen as an immunotherapy product.
"We are working hard to advance our Clevegen programme, as announced recently, towards clinical use as a new onco-immunological alternative," said Faron Chief Executive Markku Jalkanen.
Shares in Faron were trading flat at 275.00 pence on Monday.
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance
Copyright 2015 Alliance News Limited. All Rights Reserved.
Latest FARN News
- Faron Says Traumakine Trial Did Not Produce Expected Results
11 May 2018 - WINNERS & LOSERS SUMMARY: Virgin Money Gains On CYBG Takeover Offer
8 May 2018 - Faron Pharmaceuticals Shares Dive As Traumakine Fails In Latest Test
8 May 2018 - LONDON MARKET EARLY CALL: Stocks Called Lower As Iran Fears Boost Oil
8 May 2018 - UK Earnings, Trading Statements Calendar - Next 7 Days
1 May 2018 - Tiziana Appoints Leopoldo Zambeletti As Non-Executive Director
4 Apr 2018 - Faron Pharmaceuticals makes solid progress with drug programmes
9 Feb 2017 - Faron Pharma granted protection for IFN-beta by Finnish patent office
31 Oct 2016
Related News
IN BRIEF: Faron Pharmaceuticals fined EUR30,000 by Nasdaq Helsinki
Faron Pharmaceuticals Ltd - Turku, Finland-based cancer drug developer - Says the Disciplinary Committee of Nasdaq Helsinki Ltd has imposed an EUR30,0...
WINNERS & LOSERS: James Cropper sees earnings up; Block sells stake
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday.
Faron Pharmaceuticals News
Faron Says Traumakine Trial Did Not Produce Expected Results
LONDON (Alliance News) - Faron Pharmaceuticals Ltd said Friday that initial review of the Phase III trial for Traumakine drug used for the treatment o...
WINNERS & LOSERS SUMMARY: Virgin Money Gains On CYBG Takeover Offer
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 4.1...
Faron Pharmaceuticals Shares Dive As Traumakine Fails In Latest Test
LONDON (Alliance News) - Shares in Finnish firm Faron Pharmaceuticals Oy plunged on Tuesday as the company reported "extremely disappointing" results ...
LONDON MARKET EARLY CALL: Stocks Called Lower As Iran Fears Boost Oil
LONDON (Alliance News) - Stock prices in London are seen opening lower on Tuesday following Monday's UK bank holiday as Chinese exports recovered at a...
UK Earnings, Trading Statements Calendar - Next 7 Days
Wednesday 2 May Direct Line Insurance GroupQ1 ResultsConvaTec GroupQ1 GroupHalf
Tiziana Appoints Leopoldo Zambeletti As Non-Executive Director
LONDON (Alliance News) - Tiziana Life Sciences PLC, a biotechnology company developing drugs for cancer and autoimmune diseases, said Wednesday Leopol...
Faron Pharmaceuticals makes solid progress with drug programmes
(ShareCast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals updated the market on Thursday, ahead of its full year 2016 audited ...
Faron Pharma granted protection for IFN-beta by Finnish patent office
(ShareCast News) - Faron Pharmaceuticals' patent application to protect the intravenous use of interferon-beta, a cytokine protein, in a novel formula...
Follow the stocks
